Exiting the pandemic together: achieving global immunity and equity
2023-09-08
(Press-News.org)
“While vaccination has been successful for the general population, it is crucial not to overlook the needs of immunocompromised individuals.”
BUFFALO, NY- September 8, 2023 – A new editorial paper was published in Oncoscience (Volume 10) on September 1, 2023, entitled, “Exiting the pandemic together: achieving global immunity and equity.”
In this new editorial, researchers Yuxin Ying, Jola Bytyci and Lennard YW Lee from Oxford Medical School discuss their recent investigation into the effectiveness of the third booster vaccine, entitled, “COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.”
Overall, the study found that the third dose booster improved vaccine effectiveness across various measures. However, the benefits of the booster were not as significant for patients with cancer when compared to the general population. This is because immunocompromised (IC) individuals, including those with cancer, have a diminished response to vaccination.
As a result, they continue to remain at a high risk of experiencing breakthrough infections and severe cases of COVID-19. Unfortunately, vaccination alone does not provide an adequate level of protection for these groups. Consequently, additional measures such as prophylactic antibodies are internally agreed to be the standard of care to address the ongoing impact of the pandemic on affected individuals.
“This study represents the largest global evaluation of the efficacy of the third dose booster vaccine against SARS-CoV-2.”
Continue reading: DOI: https://doi.org/10.18632/oncoscience.585
Correspondence to: Yuxin Ying
Email: yuxin.ying@sjc.ox.ac.uk
Keywords: COVID-19, immunocompromised, vaccination, breakthrough infection, cancer
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
Twitter
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
Oncoscience Journal Office
6666 East Quaker Str., Suite 1D
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 4
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-09-08
September 8, 2023 – A series of pre-clinical studies provide important first steps in developing techniques of robotic bladder transplantation in humans, as reported in the October issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Our study is the first report of bladder auto-transplantation in heart-beating, brain-dead human research donors as a necessary preparatory step toward clinical bladder transplantation in living patients," comments Inderbir S. Gill, MD, of Keck School of Medicine, University of Southern California, Los Angeles.
Preclinical ...
2023-09-08
Oak Ridge National Laboratory has launched a new entrepreneurial start-up program, Safari, as an addition to the Department of Energy Office of Technology Transitions Practices to Accelerate the Commercialization of Technologies, or PACT, program. Safari seeks to connect post-exit entrepreneurs with commercially relevant technologies developed by world-leading scientific experts, which could provide the basis for a new business.
A post-exit or serial entrepreneur has established and sold at least one company.
“An experienced entrepreneur is likely to succeed in subsequent business ventures,” said Jennifer ...
2023-09-08
Scientific research depends on collaboration between researchers and institutions. But over the past decade, there has been a surge of large-scale research projects involving extraordinarily large numbers of researchers, from dozens to hundreds, all working on a common project. Examples of this trend include ManyBabies, centred on infant cognition and development, and ManyManys, focused on comparative cognition and behaviour across animal taxa. These kinds of projects, known as big team science (BTS), benefit from pooled human and material ...
2023-09-08
PHILADELPHIA— The blood-brain barrier (BBB) has been found to play a significant role in controlling behavior critical to how ant colonies function, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The implications of this research on the intricate mechanisms behind ant behavior go beyond the world of ants. The findings, published this week in Cell, hint at similar mechanisms at play in other species, including mammals.
In ants, along with other animals, the BBB consists of tightly locked cells that protect the brain from germs and other harmful substances. The protective barrier plays a key role in how the brain and ...
2023-09-08
Metastasis is the leading cause of death in cancer, occurring when a cell leaves the primary tumour, passes into the bloodstream and lymphatic system and reaches distant organs. Non-invasive collection of these circulating tumour cells is essential for the study of cell biology, the diagnosis and prognosis in cancer research, and drug development. As a general rule, the concentration of cancer cells found in blood is very small with respect to other cell types, and traditional methods of collecting them in a viable way are laborious.
“We wanted to come up with a device capable ...
2023-09-08
September 8, 2023 — As part of its active efforts to dismantle systemic racism and promote principles of equity and inclusion within its editorial processes and content, Obstetrics & Gynecology, the official journal of the American College of Obstetricians and Gynecologists, has devoted its entire October 2023 issue to addressing racism in reproductive health. The journal is published in the Lippincott portfolio by Wolters Kluwer.
A journal with such a rich history must root out inequity
"Let ...
2023-09-08
UPTON, NY—Researchers at the Center for Functional Nanomaterials (CFN), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Brookhaven National Laboratory, and Northrop Grumman, a multinational aerospace and defense technology company, have found a way to maintain valley polarization at room temperature using novel materials and techniques. This discovery could lead to devices that store and process information in novel ways using this technology without the need to keep them at ultra-low temperatures. Their ...
2023-09-08
In a groundbreaking study published on July 26, 2023, in the journal Environmental Science and Ecotechnology, researchers from Huazhong University of Science and Technology have introduced "Meta-Sorter," an AI-based method that leverages neural networks and transfer learning to significantly improve biome labeling for thousands of microbiome samples in the MGnify database, especially those with incomplete information. The Meta-Sorter approach comprises two crucial steps. Firstly, a neural network model is meticulously constructed using 118,592 microbial samples from 134 biomes and their respective biome ontology, boasting an impressive average ...
2023-09-08
BOSTON – Researchers who previously developed the first 3D human cell culture models of Alzheimer’s disease (AD) that displays two major hallmarks of the condition—the generation of amyloid beta deposits followed by tau tangles—have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology.
As reported in the journal Neuron, the Massachusetts General Hospital (MGH)–led team has uncovered promising results suggesting that irisin-based ...
2023-09-08
About The Study: In this study of health care workers who received a COVID-19 vaccine, an influenza vaccine, or both, co-administration was not associated with substantially inferior immune response or to more frequent adverse events compared with COVID-19 vaccine administration alone, supporting the co-administration of these vaccines.
Authors: Gili Regev-Yochay, M.D., of the Sheba Medical Center in Ramat Gan, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.32813)
Editor’s ...
LAST 30 PRESS RELEASES:
[Press-News.org] Exiting the pandemic together: achieving global immunity and equity
